Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Filed Aug 5, 2011 · 10-Q · 36 days after period end · 0001193125-11-212333
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $2.42M | $1.13M |
| Net Income | -$2.82M | -$7.62M |
| EPS Diluted | -$0.02 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 5, 2011 · 36 d after period end
